Cite
APA Citation
Duchemann, B., Naigeon, M., Auclin, E., Ferrara, R., Cassard, L., Jouniaux, J., Boselli, L., Grivel, J., Desnoyer, A., Danlos, F., Mezquita, L., Caramella, C., Marabelle, A., Besse, B., & Chaput, N. (2022). cD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers. Journal for immunotherapy of cancer, 10(2), . http://access.bl.uk/ark:/81055/vdc_100150524100.0x000016